1
|
Chen BY, Wang CY, Chen WY and Ma JX:
Altered TGF-β2 and bFGF expression in scleral desmocytes from an
experimentally-induced myopia guinea pig model. Graefes Arch Clin
Exp Ophthalmol. 251:1133–1144. 2013. View Article : Google Scholar : PubMed/NCBI
|
2
|
Hodos W and Kuenzel WJ: Retinal-image
degradation produces ocular enlargement in chicks. Invest
Ophthalmol Vis Sci. 25:652–659. 1984.PubMed/NCBI
|
3
|
Nagineni CN, Cherukuri KS, Kutty V,
Detrick B and Hooks JJ: Interferonamma differentially regulates
TGF-β1 and TGF-β2 expression in human retinal pigment epithelial
cells through JAK-STAT pathway. J Cell Physiol. 210:192–200. 2007.
View Article : Google Scholar : PubMed/NCBI
|
4
|
Seko Y, Tanaka Y and Tokoro T: Scleral
cell growth is influenced by retinal pigment epithelium in vitro.
Graefes Arch Clin Exp Ophthalmol. 232:545–552. 1994. View Article : Google Scholar : PubMed/NCBI
|
5
|
Troilo D, Nickla DL, Mertz JR and Summers
Rada JA: Change in the synthesis rates of ocular retinoic acid and
scleral glycos-aminoglycan during experimentally altered eye growth
in marmosets. Invest Ophthalmol Vis Sci. 47:1768–1777. 2006.
View Article : Google Scholar : PubMed/NCBI
|
6
|
Asano K, Shikama Y, Shoji N, Hirano K,
Suzaki H and Nakajima H: Tiotropium bromide inhibits TGF-β-induced
MMP production from lung fibroblasts by interfering with smad and
MAPK pathways in vitro. Int J Chron Obstruct Pulmon Dis. 5:277–286.
2010. View Article : Google Scholar : PubMed/NCBI
|
7
|
Murphy G and Nagase H: Progress in matrix
metalloproteinase research. Mol Aspects Med. 29:290–308. 2008.
View Article : Google Scholar : PubMed/NCBI
|
8
|
Kahari V and Saarialho-Kere U: Matrix
metalloproteinases and their inhibitors in tumour growth and
invasion. Ann Med. 31:34–45. 1999. View Article : Google Scholar : PubMed/NCBI
|
9
|
Brew K, Dinakarpandian D and Nagase H:
Tissue inhibitors of metalloproteinases: evolution, structure and
function. Biochim Biophys Acta. 1477:267–283. 2000. View Article : Google Scholar : PubMed/NCBI
|
10
|
Groblewska M, Siewko M, Mroczko B and
Szmitkowski M: The role of matrix metalloproteinases (MMPs) and
their inhibitors (TIMPs) in the development of esophageal cancer.
Folia Histochem Cytobiol. 50:12–19. 2012. View Article : Google Scholar : PubMed/NCBI
|
11
|
Chirco R, Liu XW, Jung KK and Kim HR:
Novel functions of TIMPs in cell signaling. Cancer Metastasis Rev.
25:99–113. 2006. View Article : Google Scholar : PubMed/NCBI
|
12
|
Egeblad M and Werb Z: New functions for
the matrix metalloproteinases in cancer progression. Nat Rev
Cancer. 2:161–174. 2002. View
Article : Google Scholar : PubMed/NCBI
|
13
|
Sternlicht MD and Werb Z: How matrix
metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol.
17:463–516. 2001. View Article : Google Scholar : PubMed/NCBI
|
14
|
McBrien NA and Gentle A: Role of the
sclera in the development and pathological complications of myopia.
Prog Retin Eye Res. 22:307–338. 2003. View Article : Google Scholar : PubMed/NCBI
|
15
|
Gao H, Frost MR, Siegwart JT Jr and Norton
TT: Patterns of mRNA and protein expression during minus-lens
compensation and recovery in tree shrew sclera. Mol Vis.
17:903–919. 2011.PubMed/NCBI
|
16
|
Shelton L and Rada JS: Effects of cyclic
mechanical stretch on extracellular matrix synthesis by human
scleral fibroblasts. Exp Eye Res. 84:314–322. 2007. View Article : Google Scholar : PubMed/NCBI
|
17
|
Jia Y, Hu DN, Zhu D, Zhang L, Gu P, Fan X
and Zhou J: MMP-2, MMP-3, TIMP-1, TIMP-2, and TIMP-3 protein levels
in human aqueous humor: relationship with axial length. Invest
Ophthalmol Vis Sci. 55:3922–3928. 2014. View Article : Google Scholar : PubMed/NCBI
|
18
|
Jia Y, Hu DN and Zhou J: Human aqueous
humor levels of TGF- β2: relationship with axial length. Biomed Res
Int. 2014:2585912014. View Article : Google Scholar : PubMed/NCBI
|
19
|
Manise M, Holtappels G, Van Crombruggen K,
Schleich F, Bachert C and Louis R: Sputum IgE and cytokines in
asthma: relationship with sputum cellular profile. PLoS One.
8:e583882013. View Article : Google Scholar : PubMed/NCBI
|
20
|
Codices V, Martins C, Novo C, de Sousa B,
Lopes Â, Borrego M and Matos O: Dynamics of cytokines and
immunoglobulins serum profiles in primary and secondary
Cryptosporidium parvum infection: usefulness of Luminext xMAP
technology. Exp Parasitol. 133:106–113. 2013. View Article : Google Scholar : PubMed/NCBI
|
21
|
Bajracharya D, Shrestha B, Kamath A, Menon
A and Radhakrishnan R: Immunohistochemical correlation of matrix
metalloproteinase-2 and tissue inhibitors of metalloproteinase-2 in
tobacco associated epithelial dysplasia. Dis Marker.
2014:1978132014. View Article : Google Scholar
|
22
|
Seko Y, Shimokawa H and Tokoro T:
Expression of bFGF and TGF-beta 2 in experimental myopia in chicks.
Invest Ophthalmol Vis Sci. 36:1183–1187. 1995.PubMed/NCBI
|
23
|
Honda S, Fujii S, Sekiya Y and Yamamoto M:
Retinal control on the axial length mediated by transforming growth
factor-beta in chick eye. Invest Ophthalmol Vis Sci. 37:2519–2526.
1996.PubMed/NCBI
|
24
|
McBrien NA: Regulation of scleral
metabolism in myopia and the role of transforming growth
factor-beta. Exp Eye Res. 114:128–140. 2013. View Article : Google Scholar : PubMed/NCBI
|
25
|
Jobling AI, Nguyen M, Gentle A and McBrien
NA: Isoform-specific changes in scleral transforming growth
factor-β expression and the regulation of collagen synthesis during
myopia progression. J Biol Chem. 279:18121–18126. 2004. View Article : Google Scholar : PubMed/NCBI
|
26
|
Estella C, Herrer I, Atkinson SP,
Quiñonero A, Martínez S, Pellicer A and Simón C: Inhibition of
histone deacetylase activity in human endometrial stromal cells
promotes extracellular matrix remodelling and limits embryo
invasion. PLoS One. 7:e305082012. View Article : Google Scholar : PubMed/NCBI
|
27
|
Jobling AI, Wan R, Gentle A, Bui BV and
McBrien NA: Retinal and choroidal TGF-β in the tree shrew model of
myopia: isoform expression, activation and effects on function. Exp
Eye Res. 88:458–466. 2009. View Article : Google Scholar : PubMed/NCBI
|
28
|
Zhuang H, Zhang R, Shu Q, Jiang R, Chang
Q, Huang X, Jiang C and Xu G: Changes of TGF-β2, MMP-2, and TIMP-2
levels in the vitreous of patients with high myopia. Graefes Arch
Clin Exp Ophthalmol. 252:1763–1767. 2014. View Article : Google Scholar : PubMed/NCBI
|
29
|
Guggenheim JA and McBrien NA:
Form-deprivation myopia induces activation of scleral matrix
metalloproteinase-2 in tree shrew. Invest Ophthalmol Vis Sci.
37:1380–1395. 1996.PubMed/NCBI
|
30
|
Siegwart JT Jr and Norton TT: Selective
regulation of MMP and TIMP mRNA levels in tree shrew sclera during
minus lens compensation and recovery. Invest Ophthalmol Vis Sci.
46:3484–3492. 2005. View Article : Google Scholar : PubMed/NCBI
|
31
|
Chavey C, Mari B, Monthouel MN, Bonnafous
S, Anglard P, Van Obberghen E and Tartare-Deckert S: Matrix
metalloproteinases are differentially expressed in adipose tissue
during obesity and modulate adipocyte differentiation. J Biol Chem.
278:11888–11896. 2003. View Article : Google Scholar : PubMed/NCBI
|
32
|
Limaye AM, Desai KV, Chavalmane AK and
Kondaiah P: Regulation of mRNAs encoding MMP-9 and MMP-2, and their
inhibitors TIMP-1 and TIMP-2 by androgens in the rat ventral
prostate. Mol Cell Endocrinol. 294:10–18. 2008. View Article : Google Scholar : PubMed/NCBI
|
33
|
Ma DH, Chen JK, Kim WS, Hao YX, Wu HC,
Tsai RJ, Hwang DG and Zhang F: Expression of matrix
metalloproteinases 2 and 9 and tissue inhibitors of
metalloproteinase 1 and 2 in inflammation-induced corneal
neovascularization. Ophthalmic Res. 33:353–362. 2001. View Article : Google Scholar : PubMed/NCBI
|
34
|
Webb KE, Henney AM, Anglin S, Humphries SE
and McEwan JR: Expression of matrix metalloproteinases and their
inhibitor TIMP-1 in the rat carotid artery after balloon injury.
Arterioscler Thromb Vasc Biol. 17:1837–1844. 1997. View Article : Google Scholar : PubMed/NCBI
|
35
|
Lakatos G, Hritz I, Varga MZ, Juhász M,
Miheller P, Cierny G, Tulassay Z and Herszényi L: The impact of
matrix metalloproteinases and their tissue inhibitors in
inflammatory bowel diseases. Dig Dis. 30:289–295. 2012. View Article : Google Scholar : PubMed/NCBI
|
36
|
Gomez DE, De Lorenzo MS, Alonso DF and
Andrade ZA: Expression of metalloproteinases (MMP-1, MMP-2, and
MMP-9) and their inhibitors (TIMP-1 and TIMP-2) in schistosomal
portal fibrosis. Am J Trop Med Hyg. 61:9–13. 1999. View Article : Google Scholar : PubMed/NCBI
|
37
|
Knittel T, Mehde M, Grundmann A, Saile B,
Scharf JG and Ramadori G: Expression of matrix metalloproteinases
and their inhibitors during hepatic tissue repair in the rat.
Histochem Cell Biol. 113:443–453. 2000.PubMed/NCBI
|
38
|
Figueira RC, Gomes LR, Neto JS, Silva FC,
Silva ID and Sogayar MC: Correlation between MMPs and their
inhibitors in breast cancer tumor tissue specimens and in cell
lines with different metastatic potential. BMC Cancer. 9:202009.
View Article : Google Scholar : PubMed/NCBI
|
39
|
Gress TM, Müller-Pillasch F, Lerch MM,
Friess H, Buchler M and Adler G: Expression and in-situ
localization of genes coding for extracellular matrix proteins and
extracellular matrix degrading proteases in pancreatic cancer. Int
J Cancer. 62:407–413. 1995. View Article : Google Scholar : PubMed/NCBI
|
40
|
Poruk KE, Firpo MA, Scaife CL, Adler DG,
Emerson LL, Boucher KM and Mulvihill SJ: Serum osteopontin and
tissue inhibitor of metalloproteinase 1 as diagnostic and
prognostic biomarkers for pancreatic adenocarcinoma. Pancreas.
42:193–197. 2013. View Article : Google Scholar : PubMed/NCBI
|
41
|
Gardner J and Ghorpade A: Tissue inhibitor
of metalloproteinase (TIMP)-1: the TIMPed balance of matrix
metalloproteinases in the central nervous system. J Neurosci Res.
74:801–806. 2003. View Article : Google Scholar : PubMed/NCBI
|
42
|
Singh RD, Haridas N, Patel JB, Shah FD,
Shukla SN, Shah PM and Patel PS: Matrix metalloproteinases and
their inhibitors: correlation with invasion and metastasis in oral
cancer. Indian J Clin Biochem. 25:250–259. 2010. View Article : Google Scholar : PubMed/NCBI
|
43
|
Wallard MJ, Pennington CJ,
Veerakumarasivam A, Burtt G, Mills IG, Warren A, Leung HY, Murphy
G, Edwards DR, Neal DE and Kelly JD: Comprehensive profiling and
localisation of the matrix metalloproteinases in urothelial
carcinoma. Br J Cancer. 94:569–577. 2006. View Article : Google Scholar : PubMed/NCBI
|
44
|
Kossakowska AE, Huchcroft SA, Urbanski SJ
and Edwards DR: Comparative analysis of the expression patterns of
metalloproteinases and their inhibitors in breast neoplasia,
sporadic colorectal neoplasia, pulmonary carcinomas and malignant
non-Hodgkins lymphomas in humans. Br J Cancer. 73:1401–1408. 1996.
View Article : Google Scholar : PubMed/NCBI
|
45
|
Ma J, Wang J, Fan W, Pu X, Zhang D, Fan C,
Xiong L, Zhu H, Xu N, Chen R and Liu S: Upregulated TIMP-1
correlates with poor prognosis of laryngeal squamous cell
carcinoma. Int J Clin Exp Pathol. 7:246–254. 2013.PubMed/NCBI
|
46
|
Ylisirniö S, Höyhtyä M and
Turpeenniemi-Hujanen T: Serum matrix metalloproteinases −2, −9 and
tissue inhibitors of metalloproteinases −1, −2 in lung cancer -
TIMP-1 as a prognostic marker. Anticancer Res. 20:1311–1316.
2000.PubMed/NCBI
|
47
|
Moore CS and Crocker SJ: An alternate
perspective on the roles of TIMPs and MMPs in pathology. Am J
Pathol. 180:12–16. 2012. View Article : Google Scholar : PubMed/NCBI
|
48
|
McBrien NA, Cornell LM and Gentle A:
Structural and ultrastructural changes to the sclera in a mammalian
model of high myopia. Invest Ophthalmol Vis Sci. 42:2179–2187.
2001.PubMed/NCBI
|
49
|
Rada JA and Brenza HL: Increased latent
gelatinase activity in the sclera of visually deprived chicks.
Invest Ophthalmol Vis Sci. 36:1555–1565. 1995.PubMed/NCBI
|
50
|
Rada JA, Perry CA, Slover ML and Achen VR:
Gelatinase A and TIMP-2 expression in the fibrous sclera of myopic
and recovering chick eyes. Invest Ophthalmol Vis Sci. 40:3091–3099.
1999.PubMed/NCBI
|
51
|
Schippert R, Brand C, Schaeffel F and
Feldkaemper MP: Changes in scleral MMP-2, TIMP-2 and
TGFβ-2 mRNA expression after imposed myopic and hyperopic
defocus in chickens. Exp Eye Res. 82:710–719. 2006. View Article : Google Scholar : PubMed/NCBI
|
52
|
Eichler W, Friedrichs U, Thies A, Tratz C
and Wiedemann P: Modulation of matrix metalloproteinase and TIMP-1
expression by cytokines in human RPE cells. Invest Ophthalmol Vis
Sci. 43:2767–2773. 2002.PubMed/NCBI
|
53
|
Wang X, Zhu Y, Tao H, Jin C, Liu Y, Lu X,
Hu X and Fan C: Interaction of ERK1/2 and Smad2/3 signaling
pathways in TGF-β1-induced TIMP-3 expression in rat chondrocytes.
Arch Biochem Biophys. 564:229–236. 2014. View Article : Google Scholar : PubMed/NCBI
|
54
|
Leivonen SK, Lazaridis K, Decock J,
Chantry A, Edwards DR and Kähäri VM: TGF-β-elicited induction of
tissue inhibitor of metalloproteinases (TIMP)-3 expression in
fibroblasts involves complex interplay between Smad3, p38α, and
ERK1/2. PLoS One. 8:e574742013. View Article : Google Scholar : PubMed/NCBI
|
55
|
Narcisi R, Quarto R, Ulivi V, Muraglia A,
Molfetta L and Giannoni P: TGF β-1 administration during ex vivo
expansion of human articular chondrocytes in a serum-free medium
redirects the cell phenotype toward hypertrophy. J Cell Physiol.
227:3282–3290. 2012. View Article : Google Scholar : PubMed/NCBI
|
56
|
Luna J, Masamunt MC, Llach J, Delgado S
and Sans M: Palm oil tocotrienol rich fraction reduces
extracellular matrix production by inhibiting transforming growth
factor-β1 in human intestinal fibroblasts. Clin Nutr. 30:858–864.
2011. View Article : Google Scholar : PubMed/NCBI
|
57
|
Todorova L, Gürcan E, Westergren-Thorsson
G and Miller-Larsson A: Budesonide/formoterol effects on
metalloproteolytic balance in TGFβ-activated human lung
fibroblasts. Respir Med. 103:1755–1763. 2009. View Article : Google Scholar : PubMed/NCBI
|
58
|
Su S, Grover J, Roughley PJ, DiBattista
JA, Martel-Pelletier J, Pelletier JP and Zafarullah M: Expression
of the tissue inhibitor of metalloproteinases (TIMP) gene family in
normal and osteoarthritic joints. Rheumatol Int. 18:183–191. 1999.
View Article : Google Scholar : PubMed/NCBI
|
59
|
Morris KJ, Cs-Szabo G and Cole AA:
Characterization of TIMP-3 in human articular talar cartilage.
Connect Tissue Res. 51:478–490. 2010. View Article : Google Scholar : PubMed/NCBI
|